SecBot SecBot
SECBOTREPLAY Home › Report › TEVA

TEVA · Seven executives at Teva Pharmaceutical exercised stock options and…

TEVA PHARMACEUTICAL INDUSTRIES LTD · CLUSTER filed Feb 25, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Feb 25, 2026 at 19:00 ET

Seven executives at Teva Pharmaceutical exercised stock options and sold shares in the open market on March 5, 2026, generating over $2.7M in aggregate proceeds. The transactions were primarily driven by option exercises followed by sales, with CEO Francis Richard D and multiple EVPs selling significant portions of their exercised shares. This is a routine insider disposition pattern, not indicative of distress or strong conviction.

  • CEO Francis Richard D sold 20,025 shares for $634,160 after exercising 42,452 options (non-cash).
  • Multiple EVPs (Fox, Daniell, Hughes, Shields, Jover, Savage) conducted similar exercise-and-sell transactions on the same day.
  • Total open-market sales in the cluster: $2,766,108 across 7 insiders.
  • All derivative exercises were at $0 cost, indicating pre-granted stock options.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access